Resource Type

Journal Article 1468

Conference Videos 77

Conference Topics 1

Year

2024 1

2023 97

2022 147

2021 134

2020 103

2019 81

2018 91

2017 79

2016 64

2015 82

2014 53

2013 51

2012 40

2011 47

2010 54

2009 44

2008 46

2007 55

2006 54

2005 38

open ︾

Keywords

system 17

optimization 15

index system 10

system engineering 9

Artificial intelligence 8

Multi-agent system 8

management 8

management system 8

simulation 8

Qian Xuesen 7

immunotherapy 7

public health 7

China 6

modeling 6

system construction 6

COVID-19 5

engineering management 5

fault diagnosis 5

innovation 5

open ︾

Search scope:

排序: Display mode:

A tentative theory of human meridian

Tang Xiaowei,Shen Xiaolei,He Hongjian

Strategic Study of CAE 2008, Volume 10, Issue 11,   Pages 14-17

Abstract: existing experimental results, we combine the basic theory of acupunture and meridian with that of neuroendocrineimmune system and propose a new tentative theory of human meridian.We hypothesize that the human meridian system consists of neuroendocrine immune networks with numerous

Keywords: human meridian     acupunture point     neuroendocrine immune system     complex networks    

Mechanisms of “kidney governing bones” theory in traditional Chinese medicine

Dahong Ju,Meijie Liu,Hongyan Zhao,Jun Wang

Frontiers of Medicine 2014, Volume 8, Issue 3,   Pages 389-393 doi: 10.1007/s11684-014-0362-y

Abstract: Conclusions can be summarized as follows. (1) Neuroendocrine-immune network (NIN)-osteoclast regulatory” (3) The kidney in TCM can be regarded as a complex system comprising multiple functional units” Kidney deficiency refers to a deficiency in only one or more units of the kidney system and notthe whole system itself, which explains the kidney-reinforcing effect of many herbs; some herbs cankidney governing bones” unit while the latter regulates the failure of other units in the kidney system

Keywords: kidney governing bones     kidney deficiency     marrow     osteoporosis     neuroendocrine-immune network     osteoclast    

High frequency of alternative splicing variants of the oncogene in neuroendocrine tumors of the pancreas

Frontiers of Medicine   Pages 907-923 doi: 10.1007/s11684-023-1009-7

Abstract: The characteristic genetic abnormality of neuroendocrine neoplasms (NENs), a heterogeneous group of tumorsvariants (FAK6/7) were observed in 7 (87.5%) of 8 pancreatic neuroendocrineWe further tested FAK splicing variants in breast neuroendocrine carcinoma (BrNECs), and found

Keywords: FAK6/7     SRRM4     neuroendocrine neoplasms     pancreas     breast    

Hyperthermia on skin immune system and its application in the treatment of human papillomavirus-infected

Xinghua Gao, Hongduo Chen

Frontiers of Medicine 2014, Volume 8, Issue 1,   Pages 1-5 doi: 10.1007/s11684-014-0309-3

Abstract: instance, fever-range temperature (39β°C to 40β°C) can modulate the activities of immuneCytotoxic temperature (>43β°C) can create an antigen source to induce an anti-tumor immune

Keywords: hyperthermia     HPV     immune response     virus     tumor    

An Immune Agent-based Performance Rejuvenation for Grid

Xu Jian,Zhang Kun, Liu Fengyu

Strategic Study of CAE 2007, Volume 9, Issue 11,   Pages 87-91

Abstract:

Simulating biological immune mechanism to implement performance rejuvenation This paper analyzes and compares the immune process's characteristics and computing system's rejuvenation,  sets up the logical model of system rejuvenation based on immune agent abovesimulates the biological immune mechanisms to monitor resource usage and diagnose performance degradation On the basis of above an application regarding audio-video resource transaction process system

Keywords: grid     immune system     performance monitoring     software rejuvenation     immune agent    

A case of primary neuroendocrine breast carcinoma that responded to neo-adjuvant chemotherapy

Xiaolong Wei,Chunfa Chen,Didi Xi,Jinwen Bai,Wenhe Huang,Luoxiang Rong,Mingyao Wu,Guojun Zhang

Frontiers of Medicine 2015, Volume 9, Issue 1,   Pages 112-116 doi: 10.1007/s11684-014-0345-z

Abstract:

Primary neuroendocrine breast carcinoma (NEBC) is a very rare type of breast cancer.

Keywords: neuroendocrine carcinoma     neo-adjuvant therapy     breast    

Analysis of 100 consecutive cases of resectable pancreatic neuroendocrine neoplasms: clinicopathological

Yugang Cheng,Hanxiang Zhan,Lei Wang,Jianwei Xu,Guangyong Zhang,Zongli Zhang,Sanyuan Hu

Frontiers of Medicine 2016, Volume 10, Issue 4,   Pages 444-450 doi: 10.1007/s11684-016-0471-x

Abstract:

The incidence rate of pancreatic neuroendocrine neoplasms (pNENs) has increased rapidly in recent

Keywords: pancreatic neuroendocrine neoplasms     clinicopathological characteristic     Ki-67     liver metastasis     outcomes    

Advances on immune-related adverse events associated with immune checkpoint inhibitors

Yong Fan, Yan Geng, Lin Shen, Zhuoli Zhang

Frontiers of Medicine 2021, Volume 15, Issue 1,   Pages 33-42 doi: 10.1007/s11684-019-0735-3

Abstract: Immunotherapy has recently led to a paradigm shift in cancer therapy, in which immune checkpoint inhibitorsnon-specific activation of effector T cells, ICIs are remarkably associated with a substantial risk of immune-related

Keywords: cancer     immunotherapy     immune checkpoint inhibitors     immune-related adverse events     review    

Natural killer cells in liver diseases

Meijuan Zheng, Haoyu Sun, Zhigang Tian

Frontiers of Medicine 2018, Volume 12, Issue 3,   Pages 269-279 doi: 10.1007/s11684-018-0621-4

Abstract: NK cell activation, well known for its role in the immune surveillance against tumor and pathogen-infectedUnder the setting of liver diseases, NK cells are of great importance for stimulating or inhibiting immuneresponses, leading to either immune activation or immune tolerance.

Keywords: natural killer cell     phenotype     immune activation     immune tolerance     liver diseases    

Persistence of humoral and cellular immune response after SARS-CoV-2 infection: opportunities and challenges

Tangchun Wu

Frontiers of Medicine 2020, Volume 14, Issue 6,   Pages 816-819 doi: 10.1007/s11684-020-0823-4

Heterogeneity of the tumor immune microenvironment and clinical interventions

Frontiers of Medicine 2023, Volume 17, Issue 4,   Pages 617-648 doi: 10.1007/s11684-023-1015-9

Abstract: Heterogeneity of the tumor immune microenvironment and clinical interventions

Keywords: Heterogeneity tumor immune    

Molecular classification and precision therapy of cancer: immune checkpoint inhibitors

Yingyan Yu

Frontiers of Medicine 2018, Volume 12, Issue 2,   Pages 229-235 doi: 10.1007/s11684-017-0581-0

Abstract: MSI-H status due to dMMR and characterized by increased neoantigen load, which elicits intense host immune

Keywords: molecular classification     precision medicine     pembrolizumab     PD-1/PD-L1     MSI-H    

SARS-CoV-2 variants, immune escape, and countermeasures

Frontiers of Medicine 2022, Volume 16, Issue 2,   Pages 196-207 doi: 10.1007/s11684-021-0906-x

Abstract: Although many countries have promoted roll-out vaccination, the immune barrier has not yet been fully

Keywords: SARS-CoV-2     COVID-19     vaccine     immune escape     breakthrough     prevention    

Multi-target combinatory strategy to overcome tumor immune escape

Frontiers of Medicine 2022, Volume 16, Issue 2,   Pages 208-215 doi: 10.1007/s11684-022-0922-5

Abstract: Immune therapy has become the fourth approach after surgery, chemotherapy, and radiotherapy in cancerMany immune checkpoints were identified in the last decade since ipilimumab, which is the first immuneHowever, fewer people are benefitting from immune checkpoint inhibitor treatment in solid cancers.Along with the characterization of more immune checkpoints, the combinatory treatment of multi-immuneIn this work, the author focuses on the combination therapy of multiple immune checkpoints (does not

Keywords: immune checkpoints     multi-target     immune escape     immune-related adverse events     combination therapy    

Estimating the number of Chinese cancer patients eligible for and benefit from immune checkpoint inhibitors

Frontiers of Medicine 2022, Volume 16, Issue 5,   Pages 773-783 doi: 10.1007/s11684-021-0902-1

Abstract: The total number of cancer patients who are eligible for and will benefit from immune checkpoint inhibitorspatients with eligibility and response to ICIs based on the 2015 Chinese cancer statistics and the immune

Keywords: benefit     China     eligibility     immune checkpoint inhibitor     public health    

Title Author Date Type Operation

A tentative theory of human meridian

Tang Xiaowei,Shen Xiaolei,He Hongjian

Journal Article

Mechanisms of “kidney governing bones” theory in traditional Chinese medicine

Dahong Ju,Meijie Liu,Hongyan Zhao,Jun Wang

Journal Article

High frequency of alternative splicing variants of the oncogene in neuroendocrine tumors of the pancreas

Journal Article

Hyperthermia on skin immune system and its application in the treatment of human papillomavirus-infected

Xinghua Gao, Hongduo Chen

Journal Article

An Immune Agent-based Performance Rejuvenation for Grid

Xu Jian,Zhang Kun, Liu Fengyu

Journal Article

A case of primary neuroendocrine breast carcinoma that responded to neo-adjuvant chemotherapy

Xiaolong Wei,Chunfa Chen,Didi Xi,Jinwen Bai,Wenhe Huang,Luoxiang Rong,Mingyao Wu,Guojun Zhang

Journal Article

Analysis of 100 consecutive cases of resectable pancreatic neuroendocrine neoplasms: clinicopathological

Yugang Cheng,Hanxiang Zhan,Lei Wang,Jianwei Xu,Guangyong Zhang,Zongli Zhang,Sanyuan Hu

Journal Article

Advances on immune-related adverse events associated with immune checkpoint inhibitors

Yong Fan, Yan Geng, Lin Shen, Zhuoli Zhang

Journal Article

Natural killer cells in liver diseases

Meijuan Zheng, Haoyu Sun, Zhigang Tian

Journal Article

Persistence of humoral and cellular immune response after SARS-CoV-2 infection: opportunities and challenges

Tangchun Wu

Journal Article

Heterogeneity of the tumor immune microenvironment and clinical interventions

Journal Article

Molecular classification and precision therapy of cancer: immune checkpoint inhibitors

Yingyan Yu

Journal Article

SARS-CoV-2 variants, immune escape, and countermeasures

Journal Article

Multi-target combinatory strategy to overcome tumor immune escape

Journal Article

Estimating the number of Chinese cancer patients eligible for and benefit from immune checkpoint inhibitors

Journal Article